Search: WFRF:(Hilgendorf Constanze) >
Utility of in vitro...
Utility of in vitro systems and preclinical data for the prediction of human intestinal first-pass metabolism during drug discovery and preclinical development
-
- Karlsson, Fredrik, 1984 (author)
- Chalmers tekniska högskola,Chalmers University of Technology,AstraZeneca AB
-
- Bouchene, Salim (author)
- AstraZeneca AB
-
- Hilgendorf, Constanze (author)
- AstraZeneca AB
-
show more...
-
- Dolgos, Hugues (author)
- AstraZeneca AB
-
- Peters, Sheila Annie (author)
- AstraZeneca AB
-
show less...
-
(creator_code:org_t)
- 2013-08-05
- 2013
- English.
-
In: Drug Metabolism and Disposition. - : American Society for Pharmacology & Experimental Therapeutics (ASPET). - 1521-009X .- 0090-9556. ; 41:12, s. 2033-2046
- Related links:
-
https://research.cha...
-
show more...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- A growing awareness of the risks associated with extensive intestinal metabolism has triggered an interest in developing robust methods for its quantitative assessment. This study explored the utility of intestinal S9 fractions, human liver microsomes, and recombinant cytochromes P450 to quantify CYP3A-mediated intestinal extraction in humans for a selection of marketed drugs that are predominantly metabolized by CYP3A4. A simple competing rates model is used to estimate the fraction of drug escaping gut wall metabolism (f g ) from in vitro intrinsic clearance in humans. The f g values extrapolated from the three in vitro systems used in this study, together with literature-derived f g from human intestinal microsomes, were validated against f g extracted from human in vivo pharmacokinetic (PK) profiles using a generic whole-body physiologically-based pharmacokinetic (PBPK) model. The utility of the rat as a model for human CYP3A-mediated intestinal meta bolism was also evaluated. Human f g from PBPK compares well with that from the grapefruit juice method, justifying its use for the evaluation of human in vitro systems. Predictive performance of all human in vitro systems was comparable [root mean square error (RMSE) = 0.22-0.27; n = 10]. Rat f g derived from in vivo PK profiles using PBPK has the lowest RMSE (0.19; n = 11) for the prediction of human f g for the selected compounds, most of which have a fraction absorbed close to 1. On the basis of these evaluations, the combined use of f g from human in vitro systems and rats is recommended for the estimation of CYP3A4-mediated intestinal metabolism in lead optimization and preclinical development phases.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Farmaceutiska vetenskaper (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Pharmaceutical Sciences (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinsk bioteknologi -- Biomedicinsk laboratorievetenskap/teknologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Medical Biotechnology -- Biomedical Laboratory Science/Technology (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Farmakologi och toxikologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Pharmacology and Toxicology (hsv//eng)
Publication and Content Type
- art (subject category)
- ref (subject category)
Find in a library
To the university's database